417 related articles for article (PubMed ID: 24936941)
1. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.
Khan MA; DeCroos FC; Storey PP; Shields JA; Garg SJ; Shields CL
Retina; 2014 Sep; 34(9):1750-6. PubMed ID: 24936941
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
Song JH; Bae JH; Rho MI; Lee SC
Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
[TBL] [Abstract][Full Text] [Related]
3. Combined photodynamic therapy with intravitreal bevacizumab injections for polypoidal choroidal vasculopathy: long-term visual outcome.
Kang HM; Koh HJ; Lee CS; Lee SC
Am J Ophthalmol; 2014 Mar; 157(3):598-606.e1. PubMed ID: 24269378
[TBL] [Abstract][Full Text] [Related]
4. Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: An optical coherence tomography angiography study.
Furino C; Di Antonio L; Grassi MO; Rispoli M; Reibaldi M; Niro A; Alessio G
Eur J Ophthalmol; 2019 May; 29(3):323-329. PubMed ID: 30101614
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization.
Kang HM; Koh HJ
Am J Ophthalmol; 2013 Apr; 155(4):713-9, 719.e1. PubMed ID: 23219069
[TBL] [Abstract][Full Text] [Related]
8. Subfoveal choroidal thickness in idiopathic choroidal neovascularization and treatment outcomes after intravitreal bevacizumab therapy.
Kim H; Lee K; Lee CS; Byeon SH; Lee SC
Retina; 2015 Mar; 35(3):481-6. PubMed ID: 25313710
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor monotherapy versus combination treatment with photodynamic therapy for subfoveal choroidal neovascularization secondary to causes other than age-related macular degeneration.
Chen L; Miller JW; Vavvas D; Kim IK
Retina; 2011 Nov; 31(10):2078-83. PubMed ID: 21691258
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.
Song WK; Koh HJ; Kwon OW; Byeon SH; Lee SC
Acta Ophthalmol; 2009 Feb; 87(1):100-1. PubMed ID: 19178391
[No Abstract] [Full Text] [Related]
11. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
Myung JS; Bhatnagar P; Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Freund KB
Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818
[TBL] [Abstract][Full Text] [Related]
12. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
[TBL] [Abstract][Full Text] [Related]
13. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
Sakai T; Ohkuma Y; Kohno H; Hayashi T; Watanabe A; Tsuneoka H
Br J Ophthalmol; 2014 Dec; 98(12):1642-8. PubMed ID: 25053762
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for choroidal neovascularization associated with choroidal nevus.
Chiang A; Bianciotto C; Maguire JI; Park CH; Baker PS; Shields JA; Shields CL
Retina; 2012 Jan; 32(1):60-7. PubMed ID: 21886019
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.
Jang JH; Kim KH; Lee SJ; Park JM
Korean J Ophthalmol; 2012 Dec; 26(6):478-80. PubMed ID: 23204807
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.
Moon SW; Kim MS; Kim ES; Yu SY; Kwak HW
Ophthalmologica; 2011; 225(3):169-75. PubMed ID: 21273795
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
[TBL] [Abstract][Full Text] [Related]
19. Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy.
Jyothi S; Chowdhury HR; Chong V; Sivaprasad S
Eye (Lond); 2010 Jun; 24(6):1018-23. PubMed ID: 19893588
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
